Skip to main content

The Aesthetic Society Year in Review 2023/2024

Video

Catch up on the exciting Aesthetic Society accomplishments and advances that took place in 2023.

Related Articles

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”